Home › Companies › KYMERA THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and KYMERA THERAPEUTICS INC.’s Form 8-K, filed 2025-06-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore KYMERA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are KYMERA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jeffrey Albers, J.D., MBA | 55,765,189 | -- | -- | 3,142,251 | 2,748,381 | Majority: yes |
| Elect Director: Felix J. Baker, Ph.D. | 51,745,887 | -- | -- | 7,161,553 | 2,748,381 | Majority: yes |
| Proposal 2: Non-Binding, Advisory Vote on Compensation of the Company's Named Executive Officers The shareholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers | 54,364,880 | 4,531,413 | 11,147 | -- | 2,748,381 | Majority: yes |
| Proposal 3: Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The shareholders of the Company ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal yea | 61,644,725 | 4,768 | 6,328 | -- | 0 | Majority: yes |
Source: KYMERA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-27 — read the filing on EDGAR.
Each item below shows how the 193 asset managers that disclosed a KYMERA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held 2025-06-25.
Combines 10 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
KYMERA THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Non-Binding, Advisory Vote on Compensation of the Company's Named Executive Officers The shareholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company's named executi”): 54,364,880 for, 4,531,413 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,112,714 outstanding shares: 83% for, 7% against (90% of the company cast a for/against vote).
The 190 asset managers below cast 92% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 11,521,944 | 0 | 0 | 0 | For |
| Vanguard | 9,281,418 | 405 | 0 | 0 | For |
| Fidelity | 7,181,796 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 5,995,929 | 0 | 0 | 0 | For |
| Wellington | 5,390,449 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 4,896,462 | 0 | 0 | 0 | For |
| BVF INC/IL | 4,607,955 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,829,980 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 2,791,209 | 0 | 0 | 0 | For |
| BlackRock | 2,655,938 | 94 | 0 | 0 | For |
| State Street | 1,337,923 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,101,087 | 0 | 0 | 0 | For |
| Capital Group | 95 | 1,033,782 | 0 | 0 | Against |
| Capital Research Global Investors | 0 | 1,033,782 | 0 | 0 | Against |
| Redmile Group, LLC | 0 | 983,413 | 0 | 0 | Against |
| Charles Schwab | 773,561 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 593,000 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 525,138 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0 | 503,636 | 0 | 0 | Against |
| Rock Springs Capital Management LP | 464,449 | 0 | 0 | 0 | For |
| MFS | 0 | 447,732 | 0 | 0 | Against |
| JENNISON ASSOCIATES LLC | 0 | 418,727 | 0 | 0 | Against |
| BRAIDWELL LP | 392,764 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,284 | 280,650 | 0 | 0 | Against |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 263,673 | 0 | 0 | 0 | For |
Showing the 25 largest of 190 asset managers. See all 190 in the interactive database.
Meeting held 2025-06-25.
Combines 5 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
KYMERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Felix J. Baker, Ph.D.”): 51,745,887 for, 7,161,553 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,112,714 outstanding shares: 79% for, 11% withheld (90% of the company cast a for/withheld vote).
The 65 asset managers below cast 100% of the shares they voted on this item FOR (20,153,415 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,142,775 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,957,425 | 0 | 0 | 0 | For |
| Fidelity | 3,060,220 | 0 | 17,284 | 0 | For |
| BlackRock | 0 | 0 | 1,168,188 | 0 | Abstain |
| Capital Group | 1,033,782 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 525,138 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 447,732 | 0 | Abstain |
| Charles Schwab | 386,609 | 0 | 0 | 0 | For |
| Prudential/PGIM | 274,195 | 0 | 4,494 | 0 | For |
| State Street | 726 | 0 | 248,648 | 0 | Abstain |
| Hartford | 237,696 | 0 | 0 | 0 | For |
| Equitable | 19,144 | 0 | 120,330 | 0 | Abstain |
| TIAA | 110,706 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 79,262 | 0 | Abstain |
| Pacific Life | 0 | 0 | 70,539 | 0 | Abstain |
| John Hancock | 49,943 | 0 | 16,839 | 0 | For |
| Lincoln Financial | 0 | 0 | 65,919 | 0 | Abstain |
| Yiheng Capital Management, L.P. | 63,854 | 0 | 0 | 0 | For |
| Northwestern Mutual | 62,582 | 0 | 0 | 0 | For |
| Brighthouse | 47,057 | 0 | 5,795 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 52,004 | 0 | Abstain |
| Transamerica | 43,263 | 0 | 0 | 0 | For |
| Victory Capital | 839 | 0 | 39,981 | 0 | Abstain |
| Harbor ETF Trust | 30,959 | 0 | 0 | 0 | For |
| Global X | 28,302 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Meeting held 2025-06-25.
Combines 5 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
KYMERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jeffrey Albers, J.D., MBA”): 55,765,189 for, 3,142,251 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,112,714 outstanding shares: 86% for, 5% withheld (90% of the company cast a for/withheld vote).
The 65 asset managers below cast 100% of the shares they voted on this item FOR (21,809,989 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,142,775 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,957,425 | 0 | 0 | 0 | For |
| Fidelity | 3,077,504 | 0 | 0 | 0 | For |
| BlackRock | 1,168,188 | 0 | 0 | 0 | For |
| Capital Group | 1,033,782 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 525,138 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 447,732 | 0 | Abstain |
| Charles Schwab | 386,609 | 0 | 0 | 0 | For |
| Prudential/PGIM | 274,195 | 0 | 4,494 | 0 | For |
| State Street | 249,054 | 0 | 320 | 0 | For |
| Hartford | 237,696 | 0 | 0 | 0 | For |
| Equitable | 94,484 | 0 | 44,990 | 0 | For |
| TIAA | 110,706 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 79,262 | 0 | Abstain |
| Pacific Life | 14,635 | 0 | 55,904 | 0 | Abstain |
| John Hancock | 49,943 | 0 | 16,839 | 0 | For |
| Lincoln Financial | 34,700 | 0 | 31,219 | 0 | For |
| Yiheng Capital Management, L.P. | 63,854 | 0 | 0 | 0 | For |
| Northwestern Mutual | 62,582 | 0 | 0 | 0 | For |
| Brighthouse | 47,057 | 0 | 5,795 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 52,004 | 0 | 0 | 0 | For |
| Transamerica | 43,263 | 0 | 0 | 0 | For |
| Victory Capital | 839 | 0 | 39,981 | 0 | Abstain |
| Harbor ETF Trust | 30,959 | 0 | 0 | 0 | For |
| Global X | 28,302 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Meeting held 2025-06-25.
99.9% Majority: yes · of votes cast
KYMERA THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The shareholders of the Company ratified the selection of Ernst & Young LLP as the Company's independent registered p”): 61,644,725 for, 4,768 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,112,714 outstanding shares: 95% for, 0.1% against (95% of the company cast a for/against vote).
The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (22,709,898 for, 264 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,142,775 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,957,425 | 0 | 0 | 0 | For |
| Fidelity | 3,077,504 | 0 | 0 | 0 | For |
| BlackRock | 1,168,188 | 0 | 0 | 0 | For |
| Capital Group | 1,033,782 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 525,138 | 0 | 0 | 0 | For |
| MFS | 447,732 | 0 | 0 | 0 | For |
| Charles Schwab | 386,609 | 0 | 0 | 0 | For |
| Prudential/PGIM | 278,689 | 0 | 0 | 0 | For |
| State Street | 249,374 | 0 | 0 | 0 | For |
| Hartford | 237,696 | 0 | 0 | 0 | For |
| Equitable | 139,474 | 0 | 0 | 0 | For |
| TIAA | 110,706 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 79,262 | 0 | 0 | 0 | For |
| Pacific Life | 70,539 | 0 | 0 | 0 | For |
| John Hancock | 66,782 | 0 | 0 | 0 | For |
| Lincoln Financial | 65,919 | 0 | 0 | 0 | For |
| Yiheng Capital Management, L.P. | 63,854 | 0 | 0 | 0 | For |
| Northwestern Mutual | 62,582 | 0 | 0 | 0 | For |
| Brighthouse | 47,058 | 0 | 5,794 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 52,004 | 0 | 0 | 0 | For |
| Transamerica | 43,263 | 0 | 0 | 0 | For |
| Victory Capital | 40,820 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 30,959 | 0 | 0 | 0 | For |
| Global X | 28,302 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Meeting held 2024-06-18 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
KYMERA THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Non-Binding, Advisory Vote on Compensation of the Company's Named Executive Officers The shareholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company's named executi”): 54,201,734 for, 1,599,511 against, per its Form 8-K filed 2024-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,112,714 outstanding shares: 83% for, 2% against (86% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (9 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 9 | 0 | 0 | 0 | For |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of KYMERA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 65,112,714 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 17.70% |
| 2 | Vanguard | 14.26% |
| 3 | Fidelity | 11.03% |
| 4 | BAKER BROS. ADVISORS LP | 9.21% |
| 5 | Wellington | 8.28% |
| 6 | Atlas Venture Life Science Advisors, LLC | 7.52% |
| 7 | BVF INC/IL | 7.08% |
| 8 | Siren, L.L.C. | 4.35% |
| 9 | Avoro Capital Advisors LLC | 4.29% |
| 10 | BlackRock | 4.08% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Avoro Capital Advisors LLC | 10.33% | DEF14A |
| T. Rowe Price | 10.29% | 13F |
| Entities affiliated with BVF Partners L.P. | 10.02% | DEF14A |
| Entities affiliated with Baker Bros. Advisors LP | 9.23% | DEF14A |
| Felix Baker, Ph.D. | 9.23% | DEF14A |
| T. Rowe Price Investment Management, Inc. | 8.39% | 13G |
| Wellington Management Group LLP | 8.15% | DEF14A |
| BVF PARTNERS L P/IL | 8.04% | 13D |
| Vanguard Group | 8.03% | 13F |
| FMR LLC | 7.85% | DEF14A |
Percentages above are of 65,112,714 shares outstanding, as reported by KYMERA THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KYMERA THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At KYMERA THERAPEUTICS INC.'s shareholder meeting held 2025-06-25, in the 2024-2025 proxy season, 193 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,037 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of our named executive officers… — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: KYMERA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-27.
KYMERA THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.